Literature DB >> 25100764

Sonographically guided therapeutic injections in the meniscoid lesion in patients with anteromedial ankle impingement syndrome.

Jean Jose1, Tarun Mirpuri2, Bryson Lesniak2, Lee Kaplan2.   

Abstract

UNLABELLED: We describe a sonographically guided technique to perform therapeutic injections for anteromedial ankle impingement syndrome. Scans are carried out using a high-frequency small footprint linear array transducer, positioned along the anteromedial aspect of the tibiotalar joint. A 25 gauge needle is advanced under direct sonographic guidance into the "meniscoid lesion" (area of scarring), and a standardized therapeutic mixture is injected extra-articularly. Image-guided injections have a positive influence on clinical decision making by improving patient management, increasing the accuracy of diagnosis, and decreasing patient pain. Sonography allows confirmation of correct injection placement, resulting in increased accuracy and more successful patient outcomes. LEVELS OF EVIDENCE: Therapeutic, Level V, Expert Opinion.
© 2014 The Author(s).

Entities:  

Keywords:  ankle sonography; anteromedial ankle impingement syndrome; meniscoid lesion; musculoskeletal ultrasound; sonographically guided injection

Mesh:

Substances:

Year:  2014        PMID: 25100764     DOI: 10.1177/1938640014543363

Source DB:  PubMed          Journal:  Foot Ankle Spec        ISSN: 1938-6400


  3 in total

Review 1.  Ankle impingement syndromes: an imaging review.

Authors:  Zachary Berman; Monica Tafur; Sonya S Ahmed; Brady K Huang; Eric Y Chang
Journal:  Br J Radiol       Date:  2016-11-25       Impact factor: 3.039

2.  The double posteromedial portals endoscopy for posterior ankle impingement syndrome in athletes.

Authors:  Nicola Maffulli; Rocco Aicale; Filippo Migliorini; Emilio Wagner; Amol Saxena; Francesco Oliva
Journal:  J Orthop Traumatol       Date:  2022-07-06

Review 3.  Ankle impingement.

Authors:  Kyle P Lavery; Kevin J McHale; William H Rossy; George Theodore
Journal:  J Orthop Surg Res       Date:  2016-09-09       Impact factor: 2.359

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.